SAN DIEGO and ADELAIDE, Australia, June 13, 2022 /PRNewswire/ — BioCina, a leading contract development and manufacturing organization (CDMO) today announced that the company has expanded its CDMO service offering to include the manufacture of plasmid DNA (pDNA) in a new dedicated GMP…
